Numinus WellnessSTU:LR23 10 FCF Margin % is 21.60% as of May. 2025. GuruFocus rates STU:LR23 with a GF Score™ of 10/100. Among 670 Healthcare Providers & Services companies, Numinus Wellness ranks worse than 92.99% on this metric.
The historical rank and industry rank for Numinus Wellness's FCF Margin % or its related term are showing as below:
STU:LR23'
s FCF Margin % Range Over the Past 10 Years
Min: -137.01 Med: 0 Max: 0
Current: -137.01
STU:LR23's FCF Margin % is ranked worse than 92.99% of 670
companies
in the Healthcare Providers & Services industry
Industry Median: 3.365
vs STU:LR23: -137.01
Numinus Wellness FCF Margin % Related Terms
Numinus Wellness FCF Margin % Historical Data
* Premium members only.
The historical data trend for Numinus Wellness's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:LR23 vs HLYK, SYRA, GBCS: FCF Margin % Comparison
For the Medical Care Facilities subindustry, Numinus Wellness's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Numinus Wellness FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Numinus Wellness's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Numinus Wellness's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Numinus Wellness (STU:LR23) has a FCF Margin % of 21.60% as of May. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Numinus Wellness and its competitors. According to the industry distribution chart, Numinus Wellness ranks #623 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 93%.
Is Numinus Wellness' FCF Margin % too high?
Numinus Wellness' current FCF Margin % is 21.60%. The Healthcare Providers & Services industry median FCF Margin % is 3.37. Numinus Wellness' value of 21.60% is 541.9% above this industry median. Based on the distribution chart, Numinus Wellness ranks #623 out of 670 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Numinus Wellness has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Numinus Wellness' FCF Margin % compare to HLYK and SYRA?
According to the Healthcare Providers & Services industry distribution chart, Numinus Wellness ranks #623 out of 670 companies for FCF Margin %. This places Numinus Wellness in the lower half of its industry. The industry median FCF Margin % is 3.37. Numinus Wellness' value of 21.60% is 541.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.37, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Numinus Wellness's current FCF Margin % of 21.60% is 541.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Numinus Wellness and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Numinus Wellness's current FCF Margin % is 21.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numinus Wellness stock overvalued right now?
Numinus Wellness (STU:LR23) has a current FCF Margin % of 21.60%. The current FCF Margin % is 21.60% and 541.9% above the Healthcare Providers & Services industry median of 3.37. Numinus Wellness' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Numinus Wellness (STU:LR23), the current FCF Margin % is 21.60% as of May. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.
10GF Score
Get the complete analysis for STU:LR23
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:LR23 has been successfully added to your 
